Discussion Paper to Explore Managing Validation Activities of CMOs
This article was originally published in The Gold Sheet
Executive Summary
Pharmaceutical manufacturers need to carefully plot out how they are going to manage the validation activities with their manufacturing partners. Not planning out these activities before the knowledge transfer can raise the ire of FDA.